Page 326 - Vitamin D and Cancer
P. 326
13 Vitamin D and Colorectal Cancer 313
84. Moan J et al (2007) Colon cancer: prognosis for different latitudes, age groups and seasons in
Norway. J Photochem Photobiol B 89(2–3):148–155
85. Ng K et al (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with col-
orectal cancer. J Clin Oncol 26(18):2984–2991
86. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and
Nutrition Board Institute of Medicine (1999) Dietary reference intakes for calcium, phospho-
rous, magnesium, vitamin D, and fluoride. Vitamin D. National Academy Press, Washington,
DC, pp 250–287
87. Heaney RP et al (2003) Human serum 25-hydroxycholecalciferol response to extended oral
dosing with cholecalciferol. Am J Clin Nutr 77(1):204–210
88. Bischoff-Ferrari HA et al (2006) Estimation of optimal serum concentrations of
25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1):18–28
89. Dawson-Hughes B, Bischoff-Ferrari HA (2007) Therapy of osteoporosis with calcium and
vitamin D. J Bone Miner Res 22(Suppl 2):V59–V63
90. Nesby-O’Dell S et al (2002) Hypovitaminosis D prevalence and determinants among African
American and white women of reproductive age: third National Health and Nutrition
Examination Survey, 1988–1994. Am J Clin Nutr 76(1):187–192
91. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding
the lowest observed adverse effect level. Am J Clin Nutr 73(2):288–294